Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

Epithelial membrane protein-2 (EMP2) and proliferative vitroretinopathy (PVR)

US Patent 9464135 · Granted Oct 11, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antibodies for the treatment of cancers2021
Compositions and methods for promoting growth of beneficial microbes to treat or2019
Diagnostic tools for response to 6-thiopurine therapy2019
Compositions and methods for promoting growth of beneficial microbes to treat or2018
Antibodies which bind to epithelial membrane protein 2 (EMP2)2017
Antibodies which bind to epithelial membrane protein 2 (EMP2)2017
Methods for diagnosis and treatment of endometrial cancer2015
Methods of treating cancer by administering EMP2 antibodies2015
Methods of treating cancer by administering EMP2 antibodies2015
Genotoxicity as a biomarker for inflammation2015
Genotoxicity as a biomarker for inflammation2015
EMP2 antibodies and methods of use thereof for causing regression of a solid tum2014